Puma Biotechnology Lands $5,000,000 New Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=6358530e-ab65-46fd-be00-ff4f9acee570&Preview=1 -
Date
11/23/2011 -
Company Name
Puma Biotechnology -
Mailing Address
10940 Wilshire Blvd Los Angeles, CA 90024 -
Company Description
Puma Biotechnology, Inc. is a development-stage biopharmaceutical company dedicated to in-licensing and developing novel therapeutics for the treatment of cancer. -
Website
http://www.pumabiotechnology.com -
Transaction Type
Venture Equity -
Transaction Amount
$5,000,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds from the financing will be used primarily to fund the continued clinical development of PB-272 (oral neratinib). -
M&A Terms
-
Venture Investor
Undisclosed
